Les Sulewski Analyst PerformanceAnalyst at OppenheimerLes Sulewski is a stock analyst at Oppenheimer in the healthcare sector, covering 11 publicly traded companies. Over the past year, Les Sulewski has issued 21 stock ratings, including buy and hold recommendations. While full access to Les Sulewski's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Les Sulewski's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings22 Last 1 YearsBuy Recommendations89.47% 17 Buy RatingsCompanies Covered11 Unique Companies Ratings Distribution19RatingsDistribution of strong buy, buy, hold, and sell ratings by Les Sulewski.RatingPercentageCount Strong Buy0.0%0 ratings Buy89.5%17 ratings Hold10.5%2 ratings Sell0.0%0 ratingsOut of 19 total stock ratings issued by Les Sulewski at Oppenheimer, the majority (89.5%) have been Buy recommendations, followed by 10.5% Hold.Best & Worst CallsBest Call000.0%TEVAMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ81.8% of companies on NASDAQ9 companiesNYSE18.2% of companies on NYSE2 companiesLes Sulewski, an analyst at Oppenheimer, currently covers 11 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare11 companies100.0%Les Sulewski of Oppenheimer specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentagePHARMACEUTICALS10 companies90.9%HEALTHCARE PROVIDERS & SERVICES1 company9.1% Les Sulewski's Ratings History at Oppenheimer Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsINVAInnoviva9/23/2026Initiated Coverage$20.98$35.00Outperform$0.0000.00% ROITEVATeva Pharmaceutical Industries9/23/2026Initiated Coverage$39.56$50.00Outperform$0.0000.00% ROICOLLCollegium Pharmaceutical9/23/2026Initiated Coverage$22.78$50.00Outperform$0.0000.00% ROIPCRXPacira BioSciences9/23/2026Initiated Coverage$24.70$32.00Outperform$0.0000.00% ROICRMDCorMedix9/23/2026Initiated Coverage$7.78$15.00Outperform$0.0000.00% ROITEVATeva Pharmaceutical Industries4/30/2026Boost Price Target$35.34$45.00Buy$0.0000.00% ROIBTMDbiote4/16/2026Lower Price Target$2.05$4.00Buy$0.0000.00% ROIVNDAVanda Pharmaceuticals3/5/2026Initiated Coverage$8.20$18.00Buy$0.0000.00% ROIAMRXAmneal Pharmaceuticals3/2/2026Boost Price Target$13.81$17.00Buy$0.0000.00% ROITEVATeva Pharmaceutical Industries2/18/2026Boost Price Target$34.21$42.00Buy$0.0000.00% ROICOLLCollegium Pharmaceutical2/10/2026Set Price Target$46.17$58.00$0.0000.00% ROITEVATeva Pharmaceutical Industries1/29/2026Boost Price Target$32.43$38.00Buy$0.0000.00% ROIVTRSViatris1/7/2026Set Price Target$12.40$16.00$0.0000.00% ROICOLLCollegium Pharmaceutical1/7/2026Set Price Target$46.21$55.00$0.0000.00% ROIBHCBausch Health Cos1/7/2026Boost Price Target$7.65$8.00Hold$0.0000.00% ROICOLLCollegium Pharmaceutical11/7/2025Boost Price Target$42.86$48.00Buy$0.0000.00% ROIPCRXPacira BioSciences11/7/2025Lower Price Target$22.30$28.00Buy$0.0000.00% ROITEVATeva Pharmaceutical Industries5/28/2025Initiated Coverage$17.92$25.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
